Tenet Healthcare Corporation (THC) 股票分析

公司概述

Tenet Healthcare Corporation operates as a diversified healthcare services entity within the United States, delivering acute care through its general hospitals alongside ambulatory care services. The company functions within the Healthcare sector, specifically the Medical Care Facilities industry, a domain characterized by high regulatory standards and significant capital intensity required for medical infrastructure. This organization employs a substantial workforce of 77,000 individuals and holds a market capitalization of $17.52 billion, reflecting its status as a major player in the national healthcare landscape. With annual revenue reaching $21.31 billion, these financial figures indicate that Tenet possesses a significant operational scale, positioning it as a key provider of essential medical services that impacts a vast segment of the domestic healthcare market.

财务健康

The company reported total revenue of $21.31 billion over the trailing twelve months, generating net income of $1.41 billion and EBITDA of $4.63 billion. The substantial gap between the $21.31 billion revenue and the $1.41 billion net income reveals a cost structure where operating expenses, including labor and supplies, consume a significant portion of gross receipts before reaching the bottom line. The business generated free cash flow of $1.68 billion, a metric that signifies strong financial flexibility allowing the firm to fund capital expenditures or service its obligations without relying solely on external financing. Operating margins sit at 17.5%, gross margins at 41.4%, and profit margins at 6.6%, illustrating the efficiency of the company's core operations relative to its cost of goods sold and total operational overhead. On the balance sheet, the firm holds $2.88 billion in cash against total debt of $14.43 billion, resulting in a debt-to-equity ratio of 160.79% that indicates a highly leveraged capital structure typical of the asset-heavy healthcare industry. Despite the leverage, the current ratio stands at 1.76, suggesting adequate short-term liquidity to cover current liabilities with current assets. Management effectiveness is highlighted by a return on equity of 27.0% and a return on assets of 8.0%, demonstrating the company's ability to generate substantial returns on shareholders' invested capital relative to its total asset base.

估值评估

The trailing twelve-month P/E ratio is 12.87, while the forward P/E is projected at 11.35, implying that the market expects earnings growth to outpace current profitability levels in the upcoming period. The price-to-book ratio is calculated at 4.11, indicating that the market values the company at a significant premium over its tangible book value, likely reflecting intangible assets or growth prospects not captured in asset totals. Alternative valuation metrics such as the price-to-sales ratio of 0.82 and an EV/EBITDA of 7.26 provide context on how investors price the company relative to its sales volume and earnings power before interest, taxes, depreciation, and amortization. The stock has traded between a 52-week low of $109.82 and a high of $247.21, placing the current trading price within this established range and offering a historical reference for volatility assessment. With a beta of 1.50, the stock exhibits price volatility that is 50% higher than the broader market, signaling that price movements are more sensitive to general market fluctuations than a typical index stock.

Growth & Income

Revenue growth stands at 8.9% year-over-year, while earnings growth accelerates to 27.6%, indicating that profitability is expanding at a rate significantly faster than top-line sales. This divergence suggests improving operational leverage or cost efficiencies that are translating into higher net income margins. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning it retains all earnings to fuel expansion, debt reduction, or share buybacks rather than distributing cash to shareholders. Consequently, the overall growth and income profile for Tenet Healthcare Corporation is defined by capital appreciation potential and internal reinvestment rather than passive income generation through dividends.